US equities
|
MU
$1,088.00
▲+4.06%
NVDA
$237.47
▼-0.74%
SNDK
$1,692.42
▲+1.92%
SPCX
$167.60
▼-2.51%
AMD
$645.86
▼-0.55%
AAPL
$336.67
▲+0.91%
TSLA
$377.81
▼-0.75%
META
$721.31
▼-2.38%
MU
$1,088.00
▲+4.06%
NVDA
$237.47
▼-0.74%
SNDK
$1,692.42
▲+1.92%
SPCX
$167.60
▼-2.51%
AMD
$645.86
▼-0.55%
AAPL
$336.67
▲+0.91%
TSLA
$377.81
▼-0.75%
META
$721.31
▼-2.38%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Cellbxhealth Plc ADR
(OP:
ANPCY
)
0.0670
UNCHANGED
Last Price
Updated: 2:45 PM EST, Dec 30, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cellbxhealth Plc ADR
< Previous
1
2
3
4
5
6
Next >
Angle PLC Announces Harvesting CTCs from Brain Metastasis Patients
July 09, 2021
PARSORTIX USED TO SUCCESSFULLY HARVEST CANCER CELLS FOR ANALYSIS FROM THE BLOOD OF PATIENTS WITH BRAIN METASTASIS Parsortix successful in overcoming challenges associated with isolating CTCs from brain...
From
ANGLE plc
Via
AccessWire
Topics
Intellectual Property
Angle PLC Announces Director/PDMR Shareholding
July 07, 2021
ANGLE plc Director/PDMR Shareholding Exercise of Options and Total Voting Rights GUILDFORD, SURREY / ACCESSWIRE / July 7, 2021 / ANGLE plc ('ANGLE' or the 'Company') (AIM:AGL) (OTCQX:ANPCY), a...
From
ANGLE plc
Via
AccessWire
Topics
Intellectual Property
Angle PLC announces Issue of Equity
July 02, 2021
Exercise of options and total voting rights GUILDFORD, UK / ACCESSWIRE / July 2, 2021 / ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company, announces that following the exercise of...
From
ANGLE plc
Via
AccessWire
Topics
Intellectual Property
Angle PLC Announces Result of AGM
June 30, 2021
ANGLE plc ('the Company') Result of 2021 Annual General Meeting GUILDFORD, SURREY / ACCESSWIRE / June 30, 2021 / ANGLE plc (AIM:AGL) (OTCQX:ANPCY), a world-leading liquid biopsy company, announces that...
From
ANGLE plc
Via
AccessWire
Topics
Intellectual Property
Angle PLC Announces Annual General Meeting update
June 18, 2021
GUILDFORD, SURREY / ACCESSWIRE / June 18, 2021 / ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company, confirms that its Annual General Meeting (AGM) will be held as a closed meeting...
From
ANGLE plc
Via
AccessWire
Topics
Intellectual Property
Angle PLC Announces ctDNA and CTCs have differences in EGFR mutations
June 18, 2021
- DIFFERENCES FOUND IN EGFR MUTATIONS BETWEEN ctDNA AND CTCs IN MATCHED LIQUID BIOPSIES FROM NON-SMALL LUNG CANCER PATIENTS - Study supports analysis of CTCs, together with ctDNA, from serial liquid...
From
ANGLE plc
Via
AccessWire
Topics
Death
Intellectual Property
Angle PLC Announces Update on Submission for FDA Clearance
June 04, 2021
UPDATE ON SUBMISSION FOR FDA CLEARANCE OF THE PARSORTIX SYSTEM Response to Additional Information Request made to FDA as planned GUILDFORD, UK / ACCESSWIRE / June 4, 2021 / ANGLE plc...
From
ANGLE plc
Via
AccessWire
Topics
Intellectual Property
Angle PLC Announces Potential to Prevent Breast Cancer Relapse
June 01, 2021
BREAKTHROUGH RESEARCH SUPPORTS POTENTIAL USE OF PARSORTIX IN PREVENTION OF RELAPSE OF BREAST CANCER PATIENTS IN REMISSION Parsortix system successfully used to harvest cancer cells "hibernating" in the...
From
ANGLE plc
Via
AccessWire
Topics
Intellectual Property
Angle PLC Announces Parsortix Demonstrates Oesophageal Cancer Utility
May 20, 2021
- Parsortix system consistently harvests CTCs of high quality - Research paves the way for downstream molecular analysis to enable targeted treatment in this hard-to-treat cancer GUILDFORD, UK /...
From
ANGLE plc
Via
AccessWire
Topics
Death
Intellectual Property
Angle PLC Announces Exercise of options and total voting rights
May 19, 2021
GUILDFORD, SURREY / ACCESSWIRE / May 19, 2021 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, announces that following the exercise of employee options, it has issued and...
From
ANGLE plc
Via
AccessWire
Topics
Intellectual Property
Angle PLC Announces Parsortix study uncovers targets in TNBC patients
May 11, 2021
- Parsortix system harvests intact CTCs for whole genomic sequencing identifying multiple druggable targets - Study demonstrates ctDNA and CTCs can both be analysed using the same blood sample...
From
ANGLE plc
Via
AccessWire
Topics
Intellectual Property
Angle PLC Announces Exercise of Options and Total Voting Rights
April 30, 2021
SURREY, UK / ACCESSWIRE / April 30, 2021 / ANGLE plc (AIM: AGL OTCQX: ANPCY), a world-leading liquid biopsy company, announces that following the exercise of employee options, it has issued and...
From
ANGLE plc
Via
AccessWire
Topics
Intellectual Property
Angle PLC Announces Preliminary Results
April 29, 2021
ANGLE plc ("ANGLE" or "the Company") Preliminary Results for the year ended 31 December 2020 FDA SUBSTANTIVE REVIEW PROGRESSING LAUNCH OF CLINICAL LABORATORY SERVICES FIRST LARGE-SCALE CONTRACT WITH...
From
ANGLE plc
Via
AccessWire
Angle PLC- Ovarian Cancer Study Patient Enrolment Completed
April 26, 2021
PATIENT ENROLMENT COMPLETED IN OVARIAN CANCER CLINICAL VERIFICATION STUDY Headline results from the Study expected in Q4 2021 Study designed to support launch of an ovarian cancer test from ANGLE's...
From
ANGLE plc
Via
AccessWire
Topics
Intellectual Property
Angle PLC Announces First Large-Scale Pharma Services Contract Secured
April 16, 2021
- Contract Worth Up to US$1.2 Million With Potential for Further Contracts From the Same Customer - Parsortix System Being Utilised in Cancer Drug Trials for Liquid Biopsy Longitudinal Monitoring Which...
From
ANGLE plc
Via
AccessWire
Topics
Intellectual Property
Angle PLC Announces Notice of Preliminary Results and Webcast
April 15, 2021
GUILDFORD, SURREY / ACCESSWIRE / April 15, 2021 / ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company, will be releasing its preliminary results for the year ended 31 December 2020...
From
ANGLE plc
Via
AccessWire
Topics
Intellectual Property
ANGLE's Parsortix system showcased at AACR 2021
April 12, 2021
ANGLE'S PARSORTIX SYSTEM SHOWCASED IN POSTER PRESENTATIONS AT LEADING CANCER CONFERENCE Publication of study results demonstrating the capabilities of two new assays in clinical samples at AACR 2021...
From
ANGLE plc
Via
AccessWire
Topics
Intellectual Property
< Previous
1
2
3
4
5
6
Next >
